Literature DB >> 16991126

Second primary oral and pharyngeal cancers in subjects diagnosed with oral and pharyngeal cancer.

Fabio Levi1, Van-Cong Te, Lalao Randimbison, Manuela Maspoli, Carlo La Vecchia.   

Abstract

Patients diagnosed with oral and pharyngeal (OP) cancer have a substantial excess risk of second OP cancer, but risk quantification is still uncertain and scanty information is available on the absolute excess risk of second OP cancer. We considered the risk of second OP primary cancer in a population-based series of 3,092 first primary OP cancers registered between 1974 and 2003 in the Swiss Cantons of Vaud and Neuchâtel (total population of about 786,000 inhabitants). A total of 233 second OP cancers were registered, versus 7.4 expected, corresponding to a SIR of 31.7 (95% confidence interval (CI) 27.7-36.0). The SIR was 68.5 in the first year after diagnosis of the first primary, and declined thereafter, leveling around 20. The SIR was 30.7 when the site of first neoplasm was the oral cavity, 42.5 for the tongue and 28.1 for the oropharynx or hypo-pharynx. Corresponding values for topographies of second primaries were 28.8, 50.4 and 26.2. The cumulative risk of second OP cancer 15 years after diagnosis of first OP cancer approached 22% in men and 17% in women. The incidence of first primaries increased over 20-fold between age 30-39 and 70-79, whereas there was no rise with age for second neoplasms.

Entities:  

Mesh:

Year:  2006        PMID: 16991126     DOI: 10.1002/ijc.22183

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries.

Authors:  Cristina Bosetti; Ghislaine Scelo; Shu-Chun Chuang; Jon M Tonita; Sharon Tamaro; Jon G Jonasson; Erich V Kliewer; Kari Hemminki; Elisabete Weiderpass; Eero Pukkala; Elizabeth Tracey; Jorgen H Olsen; Vera Pompe-Kirn; David H Brewster; Carmen Martos; Kee-Seng Chia; Paul Brennan; Mia Hashibe; Fabio Levi; Carlo La Vecchia; Paolo Boffetta
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

Review 2.  Multifocal epithelial tumors and field cancerization: stroma as a primary determinant.

Authors:  G Paolo Dotto
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

3.  Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.

Authors:  Duncan C Gilbert; Katie Wakeham; Ruth E Langley; Claire L Vale
Journal:  Br J Cancer       Date:  2018-11-28       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.